GCIA
CMTA

Gabelli & Co Investment Advisers’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-127,549
Closed -$3.33M – 225
2019
Q1 		$3.33M Buy
+127,549
New +$2.38M 0.43% 52

Gabelli & Co Investment Advisers's CMTA Position: Q2 2019 in Review

Gabelli & Co Investment Advisers sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 127,549 shares — an estimated $3.33M sold.

Gabelli & Co Investment Advisers first reported a position in CMTA in Q1 2019 and held it in 1 quarter. The position peaked at $3.33M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Gabelli & Co Investment Advisers reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Gabelli & Co Investment Advisers sold 127,549 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $3.33M.
  • Gabelli & Co Investment Advisers first reported a position in Clementia Pharmaceuticals Inc. in Q1 2019 and held it in 1 quarter.
  • Gabelli & Co Investment Advisers's Clementia Pharmaceuticals Inc. position peaked at $3.33M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2019, filed 2 Aug 2019.